Art and Design / MRP / Volume 2 / Issue 4 / DOI: 10.61369/mrp.6130
Cite this article
1
Download
37
Citations
125
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ARTICLE

胰十二指肠切除术胰瘘预防及管理策略的新进展

凯丽 周
Show Less
1 滨州医学院 护理学院, 滨州医学院 护理学院
MRP 2024 , 2(4), 63–65;
Published: 20 April 2024
© 2024 by the Author(s). Licensee Art and Design, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

胰腺瘘是胰十二指肠切除术的一种严重并发症,有可能引发局部或全身性的并发症,例如出血或腹腔感染,这些并发症可能会降低患者的生活质量,严重时甚至可能危及生命。本研究综合评述了胰十二指肠切除术后胰腺瘘的管理策略,探讨了如何在尊重患者生命尊严和生活质量的前提下,通过科学、合理的治疗手段,最大限度地减轻患者痛苦,降低并发症风险,为患者提供全面、细致、精准的医疗服务。

Keywords
胰十二指肠切除术
胰瘘
综述
预防策略
管理策略
References

[1] 张昕宁,董烨,周毅,等.胰十二指肠切除术后胰瘘风险评估系统的研究进展[J].临床与病理杂志,2022,42(02):506-511.
[2] 李扬,史亚波,涂建华,等.胰十二指肠切除术后胰瘘发生的危险因素及预防[J].中华肝脏外科手术学电子杂志,2023,12(3):352-355.
[3] 郑继盛,苏云,宫淑萍,等.胰十二指肠切除术后胰瘘风险预测模型研究进展[J].护理研究,2022,36(20):3636-3639.
[4]BASSI C,MARCHEGIANI G,DERVENIS C,et al.The 2016 update of the International Study Group(ISGPS)definition and grading of postoperative pancreatic fistula:11 Years After[J].Surgery,2017,161(3):584-591.
[5] 滕达,许悦,杨青松,等.胰十二指肠切除术后临床胰瘘的危险因素分析及预测评价[J].大连医科大学学报,2024,46(2):124-131.
[6]FURBETTA N,GIANARDI D,GUADAGNI S,et al.Somatostatin administration following pancreatoduodenectomy:a case-matched comparison according to surgical
technique,body mass index,American Society of Anesthesiologists’score and Fistula Risk Score[J].Surg Today,2021,51(6):1044-1053.
[7]HU B,WAN T,ZHANG W,et al.Risk factors for postoperative pancreatic fistula:Analysis of 539 successive cases of pancreaticoduodenectomy[J].World journal of gastro enterology:WJG,2016,22(34):7797-7805.
[8] 张博林,徐新建,周崇峰.胰十二指肠切除术后影响胰瘘的危险因素分析[J].新疆医学,2020,50(09):961-966.
[9] 徐煜,张军峰,花荣.奥曲肽预防胰十二指肠切除术后胰瘘的研究进展[J].外科理论与实践,2022,27(1):83-86.
[10] 余俊,任超逸,崔巍,等.胰十二指肠切除术后胰瘘风险预测模型的建立:基于2016 新版胰瘘定义及分级系统[J].临床肝胆病杂志,2024,40(04):773-781.
[11] 徐勇.胰十二指肠切除术后胰瘘的危险因素分析[D].苏州大学,2024.
[12]PILLARISETTY V G,ABBASI A,PARK J O,et al.A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula[J].HPB,2022,24(11):2029-2034.
[13]KLOMPMAKER S,van HILST J,WELLNER U F,et al.Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy:A Pan-European Propensity Score Matched Study[J].Annals of surgery,2020,271(2):356-363.

Share
Back to top
Medical Research and Practice, Electronic ISSN: 2993-9704 Print ISSN: 2993-9690, Published by Art and Design